The Chinese Journal of Clinical Pharmacology 2009 Issue 3 Randomized controlled multicenter clinical trial of cefoselis sulfate for injection in the treatment of acute bacterial infections

Randomized controlled multicenter clinical trial of cefoselis sulfate for injection in the treatment of acute bacterial infections
DU Feng;SU Xue-song;LI De-tian;WANG Qiu-yue;MIAO Li-ning;ZHENG Hong-guang

..............page:195-200

Comparison of minimum local analgesic dose of ropivacaine and bupivacaine in spinal anaesthesia for appendectomy
ZHANG Yan;HU Yun-mei;GUO Li-fang;YANG Xi-xuan;XIE Dan

..............page:201-203

Comparative clinical trial of ziprasidone and risperidone in the treatment of male schizophrenia
SUN Dong;JIANG Qin-pu;LI Jian-feng;LI Wei;YANG Lao-hu

..............page:204-206

Pharmacokinetics of cefoselis injection after a single dose in Chinese healthy volunteers
QIU Feng;ZHAO Li-mei;SUN Ya-xin;HE Xiao-jing;ZHU Xu

..............page:207-210

Pharmacokinetics of perfluoropropane after intravenous administration of perfluoropropane albumin microsphere injection in healthy human
AI Zhi-wu;SHENG Feng-xian;JIANG Ji;HU Bei;ZHUANG Ming-qiang;MA Ming-hua;YAO Jia-jia

..............page:211-214

Bioequivalence of arginine ibuprofen tablets and granules in Chinese healthy volunteers
XU Jun-yu;LIANG Yan;ZHAO Xia;ZHOU Ying;ZHAO Dong-fang;ZHANG Hui-lin;TIAN Shuo-han;LU Min;LIU Xiao;XIANG Qian;CUI Yi-min

..............page:215-218

Pharmacokinetics of isosorbide dinitrate and momonitrate metabolites in healthy volunteers following application of isosorbide dinitrate transdermal therapeutic ystem
ZHOU Ying;ZHAO Xia;SUN Pei-hong;LIU Yu-wang;ZHANG Hui-lin;CUI Yi-min

..............page:219-222

Bioequivalence of carvedilol in healthy volunteers
XIA Su-xia;TANG Si;WANG Yue-min;ZHANG Shi-liang;HUANG Dong-cai;ZHANG Wen-long

..............page:223-226

Bioequivalence and pharmacokinetics of spironolactone tablets in healthy volunteers
XU Dan-hua;LI Huan-de

..............page:227-230

Pharmacokinetics and safety of dihydroartemisinin injectable powder after a single dose administration in healthy subjects
LIU Yi-ming;ZENG Xing;DENG Yuan-hui;WANG Lu;FENG Yi;YANG Liu

..............page:231-234

Experimental study of effect of peptide extract from scorpion venom in interference in leukemic cell extramedullary infiltraiton
YANG Wen-hua;WANG Hui-juan;YANG Xiang-dong;SHI Zhe-xin;GAO Hong;LIU Bao-shan;YAO Fang

..............page:235-238

Study on correlation of cytochrome P4501 A2 activity with olanzapine disposition in healthy volunteers
YU Jing;LI Wen-biao;CHEN Xiao-ping;OUYANG Dong-sheng;ZHAI Yi-min;WANG Chuan-yue

..............page:239-241

Experimental study on relationship between γ-aminobutyric acid receptor and the amnestic effects which induced by enflurane and isoflurane in mice
XU Peng-cheng;HU Zhi-chao;DAI Ti-jun

..............page:242-245

Sensitivity of antibiotics to Bacillus licheniformi in Zhengchangsheng in vitro
SUN Jing;LI Hong;LI Xue-long;CUI Ke;SU Xian-ying;LI Xian-lin;ZHENG Bai-shui

..............page:246-248

Experimental study of long-term toxicity of Sanjiu weitai granules in rats
JIANG Jie;PAN Jing-yuan;YANG Hao-min;QIU Yin-sheng

..............page:249-251

Study on pharmacokinetics of ursodexycholic acid in healthy volunteers by HPLC-MS/MS
YAN Yao-dong;YANG Zhong-min;XIE Ning;ZHANG Yi-di

..............page:252-256

Advance in search for cerebrospinal fluid pharmacology in Chinese materia medica
YAN Chen;KANG Li-yuan

..............page:257-259

Effects of linezolid in the treatment of patients with pulmonary tuberculosis
ZHAO Li;FENG Xue-wei;YAN Heng-yi;LIU Hong-bo

..............page:260-263

Clinical pharmaceutical special of rutin
LIN Jing

..............page:256,263

Experimental study on effect of oxaliplatin on neuron voltage-dependent sodium current in rats
LI Ming-ying;XU Jian-ming;SONG San-tai;CHENG Jian-peng

..............page:264-266

Study of intensive insulin therapy on patients wth type 2 dibetes by preliminary diagnosis
LIU Zhen-hua;YAN Fu-qin;LI Yan;LV Juan-li

..............page:267-269

opponlinities and challenges of scientific monitoring in clinical trials
CAO Cai

..............page:270-272,276

Discussion on the size of clinical safety database of new durgs in the pre--approval phase
YANG Huan

..............page:273-276

Introduction of U.S.FDA's drug risk management system
TANG Jian-yuan

..............page:277-282

Consideration on phase Ⅱ clinical trial design for anticancer drugs
CHEN Xiao-yuan;QIAN Si-yuan;WANG Hai-xue;PENG Jian

..............page:283-288